U.S. Sen. Tammy Duckworth, D-Ill., is pushing two major pharmaceutical manufacturers for answers on the lack of access to an immunization that can prevent severe disease from respiratory syncytial virus in babies.
Duckworth questions drug manufacturers on access to RSV treatment
